Nav: Home

Surgery is more effective than drug in hyperparathyroidism post-kidney transplantation

December 16, 2015

A study led by researchers from the Nephrology group at Bellvitge Biomedical Research Institute (IDIBELL) and the University Hospital of Bellvitge (HUB), compared the results of surgery with drug therapy in patients with tertiary hyperparathyroidism, ie after a kidney transplant. The results of the research have been published in the journal of greatest impact in the Journal of the American Society of Nephrology.

This is the first clinical trial comparing these two treatments for this disease and has been funded by the Carlos III Health Institute within the call for independent clinical research projects.

Tertiary hyperparathyroidism

50% of patients with a kidney transplant presents tertiary hyperparathyroidism. This complication involves too much calcium, causing cardiovascular worsening by hypercalcemia, bone loss, and worsens the survival of the transplanted organ.

The study was performed in 30 patients. Half of them are operated and the other half have been treated with the usual drug. Researchers have found that surgery totally controls hypercalcemia, normalizes the secretion of parathyroid hormone (PTH) and improves bone density. While treatment only controls excess calcium in 67% of cases, has no effect on PTH and even slows the decline in bone density and does not stop the process.

The principal researcher of the study, Josep Maria Cruzado, explained that "if we have a surgical team with experience in this type of operation, our recommendation in these cases is to operate because it is positive both from the viewpoint of efficiency, since surgery It is a curative treatment, and from the economic point of view: the cost of surgery is equivalent to 14 months of treatment, and the drug must be taken chronically and can not be stopped."

The results of this study could change the clinical practice of tertiary hyperparathyroidism.

Cruzado has also explained that it is a minimally invasive surgery and involves only one day of hospitalization.
-end-
This study was coordinated by Josep M Cruzado, HUB Nephrology and Pablo Moreno of Surgery HUB and also collaborated in this work the nephrology, surgery, rheumatology and radiology services at HUB and further research service nephrology and kidney transplantation at the Clinical Hospital of Barcelona

Referència de l'article

Josep M. Cruzado*, Pablo Moreno†, José V. Torregrosa‡, Omar Taco*, Richard Mast§, Carmen Gómez-Vaquero?, Carolina Polo*, Ignacio Revuelta‡, José Francos†, Joan Torras*, Arantxa García-Barrasa†, Oriol Bestard* and Josep M. Grinyó*. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism. JASN December 8, 2015. doi:10.1681/ASN.2015060622

IDIBELL-Bellvitge Biomedical Research Institute

Related Kidney Transplant Articles:

New allocation system reduces racial/ethnic disparities in kidney transplant
A new kidney allocation system implemented in 2014 by the United Network for Organ Sharing (UNOS) led to a narrowing of the disparities in national kidney transplant rates among whites, blacks and Hispanics on the transplant waitlist, according to a new analysis.
Testing urine for particular proteins could be key to preventing kidney transplant failure
Testing for molecular markers in the urine of kidney transplant patients could reveal whether the transplant is failing and why, according to research presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases.
Kidney transplant success rates improve in children and infants
The success of kidney transplants has vastly improved for children over the past half-century, with young children now experiencing better long-term transplant success than adults, according to study results from a large pediatric transplant center.
Dementia and Alzheimer's disease are concerns for older kidney transplant recipients
Risks of dementia and Alzheimer's disease are higher in older kidney transplant recipients than in older adults in the general population.
CDISC, C-Path, and TransCelerate announce TA standard for kidney transplant
The Coalition for Accelerating Standards and Therapies (CFAST), with TransCelerate BioPharma, Inc., announce the availability of a new Clinical Data Interchange Standards Consortium (CDISC) Therapeutic Area Standard for Kidney Transplantation -- the first CDISC standard to address a therapeutic area in the field of solid organ transplant.
'Gift certificate' enables kidney donation when convenient and transplant when needed
A new program from Ronald Reagan UCLA Medical Center allows people to donate a kidney today, in exchange for a voucher for a friend or loved one, should they ever need a kidney transplant in the future.
Preliminary data for pre-kidney transplant being presented June 13
Early findings by researchers at the University of Cincinnati College of Medicine suggest that the use of a second generation cancer drug, carfilzomib, may provide an improved approach for the reduction of antibodies in potential kidney transplant candidates.
Mayo clinic: Long-term benefits to the liver-kidney transplant
A new study from physicians at Mayo Clinic in Rochester, found there may be long-term benefits to simultaneous liver-kidney transplantation versus kidney transplantation alone.
HPV vaccine effective in youth with kidney disease, but less so in those with a kidney transplant
Following vaccination against human papillomavirus, girls and young women with chronic kidney disease and those on dialysis had antibody levels above the threshold that indicates protection from infection.
Most kidney transplant recipients visit the emergency department after discharge
Among 10,533 kidney transplant recipients, 57 percent visited an emergency department within two years after transplantation.

Related Kidney Transplant Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...